Miliotto A - Search Results

1

NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer.

Ademuyiwa FO, Bshara W, Attwood K, Morrison C, Edge SB, Karpf AR, James SA, Ambrosone CB, O'Connor TL, Levine EG, Miliotto A, Ritter E, Ritter G, Gnjatic S, Odunsi K. Ademuyiwa FO, et al. Among authors: miliotto a. PLoS One. 2012;7(6):e38783. doi: 10.1371/journal.pone.0038783. Epub 2012 Jun 28. PLoS One. 2012. PMID: 22761704 Free PMC article.

2

Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors.

Tsuji T, Matsuzaki J, Ritter E, Miliotto A, Ritter G, Odunsi K, Old LJ, Gnjatic S. Tsuji T, et al. Among authors: miliotto a. PLoS One. 2011;6(8):e23651. doi: 10.1371/journal.pone.0023651. Epub 2011 Aug 12. PLoS One. 2011. PMID: 21858191 Free PMC article.

3

Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.

Odunsi K, Matsuzaki J, James SR, Mhawech-Fauceglia P, Tsuji T, Miller A, Zhang W, Akers SN, Griffiths EA, Miliotto A, Beck A, Batt CA, Ritter G, Lele S, Gnjatic S, Karpf AR. Odunsi K, et al. Among authors: miliotto a. Cancer Immunol Res. 2014 Jan;2(1):37-49. doi: 10.1158/2326-6066.CIR-13-0126. Cancer Immunol Res. 2014. PMID: 24535937 Free PMC article. Clinical Trial.

4

NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer.

Szender JB, Papanicolau-Sengos A, Eng KH, Miliotto AJ, Lugade AA, Gnjatic S, Matsuzaki J, Morrison CD, Odunsi K. Szender JB, et al. Among authors: miliotto aj. Gynecol Oncol. 2017 Jun;145(3):420-425. doi: 10.1016/j.ygyno.2017.03.509. Epub 2017 Apr 6. Gynecol Oncol. 2017. PMID: 28392127 Free PMC article.

5

Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer.

Daudi S, Eng KH, Mhawech-Fauceglia P, Morrison C, Miliotto A, Beck A, Matsuzaki J, Tsuji T, Groman A, Gnjatic S, Spagnoli G, Lele S, Odunsi K. Daudi S, et al. Among authors: miliotto a. PLoS One. 2014 Aug 7;9(8):e104099. doi: 10.1371/journal.pone.0104099. eCollection 2014. PLoS One. 2014. PMID: 25101620 Free PMC article.

6

HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancer.

Szender JB, Eng KH, Matsuzaki J, Miliotto A, Gnjatic S, Tsuji T, Odunsi K. Szender JB, et al. Among authors: miliotto a. Gynecol Oncol. 2016 Jul;142(1):158-162. doi: 10.1016/j.ygyno.2016.04.017. Epub 2016 Apr 23. Gynecol Oncol. 2016. PMID: 27103177 Free PMC article.

7

Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancer.

Tsuji T, Eng KH, Matsuzaki J, Battaglia S, Szender JB, Miliotto A, Gnjatic S, Bshara W, Morrison CD, Lele S, Emerson RO, Wang J, Liu S, Robins H, Lugade AA, Odunsi K. Tsuji T, et al. Among authors: miliotto a. Oncotarget. 2020 Jul 7;11(27):2669-2683. doi: 10.18632/oncotarget.27666. eCollection 2020 Jul 7. Oncotarget. 2020. PMID: 32676168 Free PMC article.

8

Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer.

Tchabo NE, Mhawech-Fauceglia P, Caballero OL, Villella J, Beck AF, Miliotto AJ, Liao J, Andrews C, Lele S, Old LJ, Odunsi K. Tchabo NE, et al. Cancer Immun. 2009 Aug 26;9:6. Cancer Immun. 2009. PMID: 19705800 Free PMC article.

9

Developmentally restricted differentiation antigens are targets for immunotherapy in epithelial ovarian carcinoma.

Godoy H, Mhawech-Fauceglia P, Beck A, Miliotto A, Miller A, Lele S, Odunsi K. Godoy H, et al. Among authors: miliotto a. Int J Gynecol Pathol. 2013 Nov;32(6):536-40. doi: 10.1097/PGP.0b013e318275a550. Int J Gynecol Pathol. 2013. PMID: 24071868 Free PMC article.

10

Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer.

Huang RY, Francois A, McGray AR, Miliotto A, Odunsi K. Huang RY, et al. Among authors: miliotto a. Oncoimmunology. 2016 Oct 28;6(1):e1249561. doi: 10.1080/2162402X.2016.1249561. eCollection 2017. Oncoimmunology. 2016. PMID: 28197366 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page